# Babylon Bio

**Canonical:** https://apis.io/providers/babylon-bio/  
**Website:** https://babylon.bio  
**APIs profiled:** 0

Babylon Bio (Babylon Biosciences) is a San Francisco-based drug discovery and development company founded in 2023 and backed by Lux Capital. Staffed by experienced medicinal chemists and biologists with a track record of discovering FDA-approved medicines, the company develops therapeutics that rescue essential functions in the brain rather than clearing emergent pathology, leveraging a proprietary high-throughput assay platform with an early focus on neurodegenerative disease including Alzheimer's. It was surfaced as a portfolio company of Lux Capital and added to the API Evangelist network. As a private, pre-commercial biotech it publishes no public API, developer portal, or documentation surface at this time.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotech, Drug Discovery, Pharmaceuticals, Therapeutics, Neuroscience, Life Sciences, Alzheimers

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/babylon-bio/). Scores are computed from the provider's own public artifacts under a published rubric.